RBA cuts the interest rate to a new low but rates may not be going lower

The offical cash rate has been lowered to 1.25% for the first time in nearly three years. While the market is expecting another cut (or three) over the coming months, this may not necessarily be the case.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It may sound counterintuitive, but the cut in the official cash rate this afternoon has coincided with a bounce in the Australian dollar.

The Aussie jumped from around 69.7 US cents to just a tat under 70 US cents after the Reserve Bank of Australia (RBA) lowered the interest rate for the first time in nearly three-years to a new record low of 1.25%.

The rally didn't last long and the dollar ended back where it started but there's a reason for the reaction.

a woman

Why rates may not be going lower

It probably has to do with the less dovish than expected statement by RBA governor Philip Lowe that accompanied the rate decision, which threw future rate cuts in doubt and prompted traders to buy the Aussie.

Economists are expecting another rate cut or two (some say even three) over the next 12 months but these expectations may need to be pared.

"The Board will continue to monitor developments in the labour market closely and adjust monetary policy to support sustainable growth in the economy and the achievement of the inflation target over time," said Dr Lowe in the statement.

This suggests to me that the RBA may be happy to sit at 1.25% for a while and only a deterioration in employment conditions will convince them to cut again.

More rate cuts may not be a good thing

This could be a more prudent move as I think the impact of further rate cuts from here will be more muted as we approach the point of diminishing returns for the cash rate. It is arguably more effective to use unconventional tools, such as quantitative easing, or fiscal policy (e.g. bigger tax cuts) to stimulate the economy from here.

The RBA statement was also more upbeat than I expected as it painted a relatively positive outlook. While the central bank acknowledged the downside risks stemming from the trade war, it pointed out that "the outlook for the global economy remains reasonable" and stuck to its GDP growth forecast of 2.75% in 2019 and 2020 for the Australian economy.

The RBA is feeling confident on the forecast because the Chinese government has taken steps to support economic growth and address risks in its financial system, while inflation is low and employment and wages growth are positive for most developed economies.

"Global financial conditions remain accommodative. Long-term bond yields and risk premiums are low. In Australia, long-term bond yields are at historically low levels," said Dr Lowe.

"Bank funding costs have also declined further, with money-market spreads having fully reversed the increases that took place last year. The Australian dollar has depreciated a little over the past few months and is at the low end of its narrow range of recent times."

Foolish takeaway

It doesn't sound like the RBA is in any rush to cut rates again but some in the market may be taking the comments with a pinch of salt, probably because of our darkening employment outlook and the amount of household debt.

Having said that, quantitative easing (should the RBA decide to go down that path) is also a negative for our dollar. It's hard to say exactly what's putting pressure on the exchange rate although I think the path of least resistance is down.

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Frustrated and shocked businesswoman reading bad news online from phone.
Share Fallers

Why Air New Zealand, Emeco, ResMed, and Westgold shares are tumbling today

These shares are having a poor session on Thursday. But why?

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Broker Notes

Buy, hold, sell: Flight Centre, SGH, and Navigator Global shares

Let's see if Morgans rates these shares as buys this week.

Read more »

A woman throws her hands in the air in celebration as confetti floats down around her, standing in front of a deep yellow wall.
Broker Notes

Bull alert! Bell Potter just put a buy rating on this ASX uranium stock

Bell Potter is bullish on this up and coming uranium developer.

Read more »

boy dressed as an eco warrior and holding a globe.
Broker Notes

Is this ASX renewable energy share a buy?

Bell Potter has released a broker note focused on this stock.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Is the ASX takeover target a buy?

Bell Potter has given its verdict on this share following the receipt of a takeover offer.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Broker Notes

10 ASX 200 shares given buy ratings this week

Brokers are positive on these shares this week. Let's see what they are recommending.

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Thursday

It looks set to be a tough session for Aussie investors.

Read more »

A group of people push and shove through the doors of a store, trying to beat the crowd.
Share Market News

Investors are buying CSL shares again. Should you?

Some experts believe that 2026 could mark the low point for the biotech company.

Read more »